Alexion Takeover Would Be Priciest Since 2008: Real M&A

If Roche Holding AG follows through with a purchase of Alexion Pharmaceuticals Inc., it may face one of the biotechnology industry’s most expensive takeover bills.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.